Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (697K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (127)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Beroud, C.
Right arrow Articles by Soussi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beroud, C.
Right arrow Articles by Soussi, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 26, Issue 1 200-204, Copyright © 1998 by Oxford University Press

ARTICLES

p53 gene mutation: software and database

C Beroud and T Soussi
Hopital Necker Enfants Malades, U383 INSERM, Paris, France.

A large number of different mutations in the p53 tumor suppressor gene have been identified in all types of cancer. As of October, 1997, this database (http:// perso.curie.fr/tsoussi ) contained >7500 mutations. Such a substantial increase since our previous reports should enable epidemiological analyses which were not previously possible. In order to analyse these new data, the UMD software has been improved. A new Web version of the UMD software enables online analysis of the database. The present report describes various improvements since the last release of the database.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. Zawacka-Pankau, N. Issaeva, S. Hossain, A. Pramanik, G. Selivanova, and A. J. Podhajska
Protoporphyrin IX Interacts with Wild-type p53 Protein in Vitro and Induces Cell Death of Human Colon Cancer Cells in a p53-dependent and -independent Manner
J. Biol. Chem., January 26, 2007; 282(4): 2466 - 2472.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. C. Ang, A. C. Joerger, S. Mayer, and A. R. Fersht
Effects of Common Cancer Mutations on Stability and DNA Binding of Full-length p53 Compared with Isolated Core Domains
J. Biol. Chem., August 4, 2006; 281(31): 21934 - 21941.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. K. Koblish, S. Zhao, C. F. Franks, R. R. Donatelli, R. M. Tominovich, L. V. LaFrance, K. A. Leonard, J. M. Gushue, D. J. Parks, R. R. Calvo, et al.
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo
Mol. Cancer Ther., January 1, 2006; 5(1): 160 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. J. Scian, K. E. R. Stagliano, M. A. E. Anderson, S. Hassan, M. Bowman, M. F. Miles, S. P. Deb, and S. Deb
Tumor-Derived p53 Mutants Induce NF-{kappa}B2 Gene Expression
Mol. Cell. Biol., November 15, 2005; 25(22): 10097 - 10110.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. J. N. Bykov, N. Issaeva, N. Zache, A. Shilov, M. Hultcrantz, J. Bergman, G. Selivanova, and K. G. Wiman
Reactivation of Mutant p53 and Induction of Apoptosis in Human Tumor Cells by Maleimide Analogs
J. Biol. Chem., August 26, 2005; 280(34): 30384 - 30391.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Li, Y. Mao, P. W. Brandt-Rauf, A. C. Williams, and R. L. Fine
Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway
Mol. Cancer Ther., June 1, 2005; 4(6): 901 - 909.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Erdal, M. Berndtsson, J. Castro, U. Brunk, M. C. Shoshan, and S. Linder
Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis
PNAS, January 4, 2005; 102(1): 192 - 197.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. J. O'Farrell, P. Ghosh, N. Dobashi, C. Y. Sasaki, and D. L. Longo
Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression
Cancer Res., November 15, 2004; 64(22): 8199 - 8207.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
D. Whitney, J. Skoletsky, K. Moore, K. Boynton, L. Kann, R. Brand, S. Syngal, M. Lawson, and A. Shuber
Enhanced Retrieval of DNA from Human Fecal Samples Results in Improved Performance of Colorectal Cancer Screening Test
J. Mol. Diagn., November 1, 2004; 6(4): 386 - 395.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Jetzt, J. A. Howe, M. T. Horn, E. Maxwell, Z. Yin, D. Johnson, and C. C. Kumar
Adenoviral-Mediated Expression of a Kinase-Dead Mutant of Akt Induces Apoptosis Selectively in Tumor Cells and Suppresses Tumor Growth in Mice
Cancer Res., October 15, 2003; 63(20): 6697 - 6706.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
J.-W. Hyun, Y.-C. Jung, H.-S. Kim, E.-Y. Choi, J.-E. Kim, B.-H. Yoon, S.-H. Yoon, Y.-S. Lee, J. Choi, H.-J. You, et al.
8-Hydroxydeoxyguanosine Causes Death of Human Leukemia Cells Deficient in 8-Oxoguanine Glycosylase 1 Activity by Inducing Apoptosis
Mol. Cancer Res., February 1, 2003; 1(4): 290 - 299.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
X P Hao, I M Frayling, J G Sgouros, M Q Du, T C Willcocks, I C Talbot, and I P M Tomlinson
The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas
Gut, June 1, 2002; 50(6): 834 - 839.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Norberg, S. Klaar, G. Karf, H. Nordgren, L. Holmberg, and J. Bergh
Increased p53 Mutation Frequency during Tumor Progression--Results from a Breast Cancer Cohort
Cancer Res., November 1, 2001; 61(22): 8317 - 8321.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
K. Leroy, V. Dumas, N. Martin-Garcia, M.-C. Falzone, M.-C. Voisin, J. Wechsler, J. Revuz, A. Creange, E. Levy, L. Lantieri, et al.
Malignant Peripheral Nerve Sheath Tumors Associated With Neurofibromatosis Type 1: A Clinicopathologic and Molecular Study of 17 Patients
Arch Dermatol, July 1, 2001; 137(7): 908 - 913.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. M. Dong, G. Traverso, C. Johnson, L. Geng, R. Favis, K. Boynton, K. Hibi, S. N. Goodman, M. D'Allessio, P. Paty, et al.
Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targets
J Natl Cancer Inst, June 6, 2001; 93(11): 858 - 865.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. S. Srivenugopal, J. Shou, S. R. S. Mullapudi, F. F. Lang Jr., J. S. Rao, and F. Ali-Osman
Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents
Clin. Cancer Res., May 1, 2001; 7(5): 1398 - 1409.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
T. Buschmann, O. Potapova, A. Bar-Shira, V. N. Ivanov, S. Y. Fuchs, S. Henderson, V. A. Fried, T. Minamoto, D. Alarcon-Vargas, M. R. Pincus, et al.
Jun NH2-Terminal Kinase Phosphorylation of p53 on Thr-81 Is Important for p53 Stabilization and Transcriptional Activities in Response to Stress
Mol. Cell. Biol., April 15, 2001; 21(8): 2743 - 2754.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. Spatz, G. Giglia-Mari, S. Benhamou, and A. Sarasin
Association between DNA Repair-deficiency and High Level of p53 Mutations in Melanoma of Xeroderma Pigmentosum
Cancer Res., March 1, 2001; 61(6): 2480 - 2486.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
N. Soufir, L. Daya-Grosjean, P. de La Salmoniere, J.-P. Moles, L. Dubertret, A. Sarasin, and N. Basset-Seguin
Association Between INK4a-ARF and p53 Mutations in Skin Carcinomas of Xeroderma Pigmentosum Patients
J Natl Cancer Inst, November 15, 2000; 92(22): 1841 - 1847.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K.-i. Masumura, K. Matsui, M. Yamada, M. Horiguchi, K. Ishida, M. Watanabe, K. Wakabayashi, and T. Nohmi
Characterization of mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the colon of gpt delta transgenic mouse: novel G:C deletions beside runs of identical bases
Carcinogenesis, November 1, 2000; 21(11): 2049 - 2056.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
Y Takagi, M Futamura, K Yamaguchi, S Aoki, T Takahashi, and S Saji
Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers
Gut, August 1, 2000; 47(2): 268 - 271.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. G. C. T. van Oijen and P. J. Slootweg
Gain-of-Function Mutations in the Tumor Suppressor Gene p53
Clin. Cancer Res., June 1, 2000; 6(6): 2138 - 2145.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
W.-H. Wen, L. Bernstein, J. Lescallett, Y. Beazer-Barclay, J. Sullivan-Halley, M. White, and M. F. Press
Comparison of TP53 Mutations Identified by Oligonucleotide Microarray and Conventional DNA Sequence Analysis
Cancer Res., May 1, 2000; 60(10): 2716 - 2722.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
V. Robert, P. Michel, J. M. Flaman, A. Chiron, C. Martin, F. Charbonnier, B. Paillot, and T. Frebourg
High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis
Carcinogenesis, April 1, 2000; 21(4): 563 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Soussi
p53 Antibodies in the Sera of Patients with Various Types of Cancer: A Review
Cancer Res., April 1, 2000; 60(7): 1777 - 1788.
[Abstract] [Full Text]

Home page
 JCOHome page
S. Temam, A. Flahault, S. Perie, G. Monceaux, F. Coulet, P. Callard, J.-F. Bernaudin, J. L. St Guily, and P. Fouret
p53 Gene Status as a Predictor of Tumor Response to Induction Chemotherapy of Patients With Locoregionally Advanced Squamous Cell Carcinomas of the Head and Neck
J. Clin. Oncol., January 14, 2000; 18(2): 385 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Tullo, A. M. D'Erchia, K. Honda, R. R. Mitry, M. D. Kelly, N. A. Habib, C. Saccone, and E. Sbisa
Characterization of p53 Mutations in Colorectal Liver Metastases and Correlation with Clinical Parameters
Clin. Cancer Res., November 1, 1999; 5(11): 3523 - 3528.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
C. A. Schmitt, M. E. McCurrach, E. de Stanchina, R. R. Wallace-Brodeur, and S. W. Lowe
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
Genes & Dev., October 15, 1999; 13(20): 2670 - 2677.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
K. S. Iwamoto, S. Fujii, A. Kurata, M. Suzuki, T. Hayashi, Y. Ohtsuki, Y. Okada, M. Narita, M. Takahashi, S. Hosobe, et al.
p53 mutations in tumor and non-tumor tissues of Thorotrast recipients: a model for cellular selection during radiation carcinogenesis in the liver
Carcinogenesis, July 1, 1999; 20(7): 1283 - 1291.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X. Xu, D. Yang, T. Wyss-Coray, J. Yan, L. Gan, Y. Sun, and L. Mucke
Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis
PNAS, June 22, 1999; 96(13): 7547 - 7552.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
C. J. Bult, D. M. Krupke, B. J. Tennent, and J. T. Eppig
A Survey of Web Resources for Basic Cancer Genetics Research
Genome Res., May 1, 1999; 9(5): 397 - 408.
[Full Text]

Home page
 Cell Growth Differ.Home page
T. Haapajärvi, K. Pitkänen, and M. Laiho
Human Melanoma Cell Line UV Responses Show Independency of p53 Function
Cell Growth Differ., March 1, 1999; 10(3): 163 - 171.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. N. Rodin and A. S. Rodin
Strand asymmetry of CpG transitions as indicator of G1 phase-dependent origin of multiple tumorigenic p53 mutations in stem cells
PNAS, September 29, 1998; 95(20): 11927 - 11932.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.